West Pharmaceutical Services, Inc. (WST)
384.02
+1.00
(+0.26%)
USD |
NYSE |
Oct 16, 16:00
383.77
-0.25
(-0.07%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Investing (Quarterly) : -43.20M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.20M |
| March 31, 2026 | -42.70M |
| December 31, 2025 | -76.10M |
| September 30, 2025 | -63.30M |
| June 30, 2025 | -75.20M |
| March 31, 2025 | -71.30M |
| December 31, 2024 | -104.80M |
| September 30, 2024 | -82.10M |
| June 30, 2024 | -101.20M |
| March 31, 2024 | -90.60M |
| December 31, 2023 | -108.80M |
| September 30, 2023 | -95.70M |
| June 30, 2023 | -82.10M |
| March 31, 2023 | -82.10M |
| December 31, 2022 | -94.80M |
| September 30, 2022 | -59.10M |
| June 30, 2022 | -66.00M |
| March 31, 2022 | -68.30M |
| December 31, 2021 | -77.40M |
| September 30, 2021 | -65.30M |
| June 30, 2021 | -55.90M |
| March 31, 2021 | -54.50M |
| December 31, 2020 | -57.60M |
| September 30, 2020 | -49.10M |
| June 30, 2020 | -40.90M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.90M |
| December 31, 2019 | -120.60M |
| September 30, 2019 | -31.60M |
| June 30, 2019 | -47.10M |
| March 31, 2019 | -28.70M |
| December 31, 2018 | -28.60M |
| September 30, 2018 | -26.50M |
| June 30, 2018 | -17.00M |
| March 31, 2018 | -28.70M |
| December 31, 2017 | -29.40M |
| September 30, 2017 | -34.00M |
| June 30, 2017 | -35.50M |
| March 31, 2017 | -34.70M |
| December 31, 2016 | -46.70M |
| September 30, 2016 | -47.90M |
| June 30, 2016 | -42.60M |
| March 31, 2016 | -38.60M |
| December 31, 2015 | -43.90M |
| September 30, 2015 | -29.50M |
| June 30, 2015 | -25.50M |
| March 31, 2015 | -30.60M |
| December 31, 2014 | -26.30M |
| September 30, 2014 | -20.70M |
| June 30, 2014 | -21.40M |
| March 31, 2014 | -35.60M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Globus Medical, Inc. | -129.05M |
| Hinge Health, Inc. | 28.62M |
| The Cooper Cos., Inc. | -69.80M |
| Becton, Dickinson & Co. | -228.00M |
| Thermo Fisher Scientific, Inc. | 164.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 124.00M |
| Cash from Financing (Quarterly) | -164.80M |
| Free Cash Flow | 436.90M |
| Free Cash Flow Per Share (Quarterly) | 1.133 |
| Free Cash Flow to Equity (Quarterly) | 85.30M |
| Free Cash Flow to Firm (Quarterly) | 82.94M |
| Free Cash Flow Yield | 1.57% |